Table 2.
Extent and Intensity of Intraprostatic Inflammation in Men without Clinical Indication for Biopsy and Negative for Prostate Cancer by Tertile of Serum PSA Concentration at Biopsy, Placebo Arm, Prostate Cancer Prevention Trial
Tertile of Serum PSA Concentration at Biopsy (ng/mL) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
P- Trend* |
||||||||||
1 (>0 to ≤0.8) | 2 (>0.8 to ≤1.5) | 3 (>1.5 to <4.0) | ||||||||
Mean | Median | IQR** | Mean | Median | IQR** | Mean | Median | IQR** | ||
N | 77 | 71 | 76 | |||||||
Extent measured as the percentage of tissue area with total inflammation*** | ||||||||||
Mean % | 6.83 | 2(0–7.5) | 9.19 | 5 (0.67–9.0) | 15.09 | 9.5(2.5–24.5) | < 0.0001 | |||
Maximum % | 9.99 | 3(0–10.0) | 14.24 | 7(2.0–15.0) | 20.80 | 13.0(5.0–32.5) | < 0.0001 | |||
Extent measured using a consensus scoring system**** | ||||||||||
Mean score for acute inflammation | ||||||||||
Intraepithelial | 0.01 | 0(0-0) | 0.04 | 0(0-0) | 0.11 | 0(0-0) | 0.06 | |||
Luminal | 0.03 | 0(0-0) | 0.03 | 0(0-0) | 0.13 | 0(0-0) | 0.007 | |||
Stromal | 0.00 | 0(0-0) | 0.05 | 0(0-0) | 0.05 | 0(0-0) | 0.2 | |||
Maximum score for acute inflammation | ||||||||||
Intraepithelial | 0.03 | 0(0-0) | 0.07 | 0(0-0) | 0.14 | 0(0-0) | 0.06 | |||
Luminal | 0.05 | 0(0-0) | 0.04 | 0(0-0) | 0.21 | 0(0-0) | 0.007 | |||
Stromal | 0.00 | 0(0-0) | 0.10 | 0(0-0) | 0.05 | 0(0-0) | 0.2 | |||
Mean score for chronic inflammation | ||||||||||
Intraepithelial | 0.55 | 0(0–1) | 0.71 | 0.5(0–1) | 1.00 | 1(0–1.5) | 0.002 | |||
Luminal | 0.04 | 0(0-0) | 0.03 | 0(0-0) | 0.08 | 0(0-0) | 0.7 | |||
Stromal | 1.24 | 1(0–2) | 1.40 | 1(0.5–2) | 1.93 | 2(0.5–3) | 0.001 | |||
Maximum score for chronic inflammation | ||||||||||
Intraepithelial | 0.84 | 0(0–1) | 1.13 | 1(0–2) | 1.38 | 1(0–2) | 0.003 | |||
Luminal | 0.08 | 0(0-0) | 0.06 | 0(0-0) | 0.11 | 0(0-0) | 0.7 | |||
Stromal | 1.70 | 1(0–3) | 1.92 | 1(1–3) | 2.50 | 2.5(1–4) | 0.001 | |||
Intensity measured using a consensus scoring system**** | ||||||||||
Mean score for acute inflammation | ||||||||||
Intraepithelial | 0.01 | 0(0-0) | 0.04 | 0(0-0) | 0.13 | 0(0-0) | 0.06 | |||
Luminal | 0.04 | 0(0-0) | 0.03 | 0(0-0) | 0.17 | 0(0-0) | 0.007 | |||
Stromal | 0.00 | 0(0-0) | 0.07 | 0(0-0) | 0.05 | 0(0-0) | 0.2 | |||
Maximum score for acute inflammation | ||||||||||
Intraepithelial | 0.03 | 0(0-0) | 0.08 | 0(0-0) | 0.18 | 0(0-0) | 0.06 | |||
Luminal | 0.08 | 0(0-0) | 0.04 | 0(0-0) | 0.30 | 0(0-0) | 0.007 | |||
Stromal | 0.00 | 0(0-0) | 0.14 | 0(0-0) | 0.07 | 0(0-0) | 0.2 | |||
Mean score for chronic inflammation | ||||||||||
Intraepithelial | 0.87 | 0(0–1) | 1.03 | 0.5(0–1) | 1.38 | 1(0–2) | 0.006 | |||
Luminal | 0.04 | 0(0-0) | 0.04 | 0(0-0) | 0.09 | 0(0-0) | 0.6 | |||
Stromal | 2.05 | 1(0–3.5) | 2.18 | 1.5(0.5–3) | 2.98 | 2.75(1–4.25) | 0.002 | |||
Maximum score for chronic inflammation | ||||||||||
Intraepithelial | 1.39 | 0(0–2) | 1.65 | 1(0–2) | 1.95 | 1(0–3) | 0.009 | |||
Luminal | 0.08 | 0(0-0) | 0.07 | 0(0-0) | 0.12 | 0(0-0) | 0.7 | |||
Stromal | 2.87 | 1(0–6) | 3.11 | 2(1–5) | 3.97 | 4(1–6) | 0.003 |
Cuzick test for trend
25 to 75th percentile
For each man, a mean of 3 biopsy cores was reviewed, one or more of which were mounted per slide. The mean or maximum of each man’s slides was used in the analysis. Possible range is 0 to 100%.
Using a slight modification of the method described by Nickel et al.16 Possible scores for extent: 0=none, 1=mild (<10% of tissue area involved by inflammatory cells), 2=multifocal (≥10% but <50%), 3=diffuse (≥50%). Possible range for extent is 0 to 3. Possible scores for grade: 1=mild, 2=moderate, and 3=severe. Possible range for intensity is 0 to 9.